Trial Profile
Clinical Trials Insight: 700046433
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 24 Aug 2022
Price :
$35
*
At a glance
- Drugs Interferon alpha (Primary)
- Indications Influenza virus infections
- Focus Therapeutic Use
- Sponsors CytoPharm
- 30 Jun 2009 New trial record.